GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (XCNQ:METX) » Definitions » Long-Term Debt

ME Therapeutics Holding (XCNQ:METX) Long-Term Debt : C$0.00 Mil (As of Feb. 2024)


View and export this data going back to 2023. Start your Free Trial

What is ME Therapeutics Holding Long-Term Debt?

ME Therapeutics Holding's Long-Term Debt for the quarter that ended in Feb. 2024 was C$0.00 Mil.

ME Therapeutics Holding's annual Long-Term Debt increased from . 20 (C$0.00 Mil) to Aug. 2022 (C$0.06 Mil) but then declined from Aug. 2022 (C$0.06 Mil) to Aug. 2023 (C$0.00 Mil).

ME Therapeutics Holding Long-Term Debt Historical Data

The historical data trend for ME Therapeutics Holding's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ME Therapeutics Holding Long-Term Debt Chart

ME Therapeutics Holding Annual Data
Trend Aug22 Aug23
Long-Term Debt
0.06 -

ME Therapeutics Holding Quarterly Data
Aug22 Dec22 May23 Aug23 Nov23 Feb24
Long-Term Debt Get a 7-Day Free Trial - - - - -

ME Therapeutics Holding  (XCNQ:METX) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

ME Therapeutics Holding Long-Term Debt Related Terms

Thank you for viewing the detailed overview of ME Therapeutics Holding's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

ME Therapeutics Holding (XCNQ:METX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (XCNQ:METX) » Definitions » Long-Term Debt
Comparable Companies
Traded in Other Exchanges
Q9T:Germany
Address
177 Robson Street, Vancouver, BC, CAN, V6B 0N3
Website
https://www.metherapeutics.com
ME Therapeutics Holding Inc operates its business through ME Therapeutics. It is a preclinical-stage biotechnology company working on novel cancer-fighting drugs in the field of Immuno-Oncology (IO). It is developing preclinical data for its myeloid-targeted candidate assets using validated cancer models.

ME Therapeutics Holding (XCNQ:METX) Headlines

No Headlines